Melatonin Treatment for Sleep Disorders
Adult Dosing Recommendations
- The American Academy of Sleep Medicine recommends a dose of 5 mg of melatonin taken between 19:00-21:00 for 28 days for adults with Delayed Sleep-Wake Phase Disorder (DSWPD) 1, 2, 3
- For adults without depression, melatonin treatment increased total sleep time by 56 minutes and decreased sleep latency by 37.7 minutes 4
- The American Academy of Sleep Medicine suggests starting with 3 mg of immediate-release melatonin for sleep disorders, with dose titration in 3 mg increments if needed 5
Pediatric Dosing Recommendations
- For children with DSWPD without comorbidities, a weight-based dose of 0.15 mg/kg taken 1.5-2.0 hours before habitual bedtime is recommended 3, 6
- For children with DSWPD and psychiatric comorbidities, fast-release melatonin at 3-5 mg is recommended, with a weight-based approach of 3 mg if <40 kg and 5 mg if >40 kg 3, 6, 7
Treatment Duration Considerations
- For adults with DSWPD, a treatment duration of 28 days has shown efficacy 1, 3
- For children without comorbidities, as little as 6 nights of treatment has demonstrated effectiveness 3, 6
- For children with psychiatric comorbidities, a 4-week treatment duration is recommended 6
Safety Profile and Adverse Effects
- No serious adverse reactions have been documented in relation to melatonin use across age groups 8, 5
- Caution is advised when prescribing to patients taking warfarin and to patients with epilepsy 8
Special Considerations
- Lower doses of melatonin may be more effective than higher doses due to potential receptor desensitization with higher doses 5
- Morning grogginess and "hangover" effects are more commonly reported with higher doses 5
- No significant differences in pubertal development have been observed in children using melatonin compared to non-users 8
Clinical Algorithm for Melatonin Use
- For adults with DSWPD, start with 3-5 mg taken between 19:00-21:00 and continue for at least 28 days to evaluate effectiveness 1, 3, 5
- For children with DSWPD (no comorbidities), calculate dose at 0.15 mg/kg and administer 1.5-2.0 hours before habitual bedtime for at least 6 nights 3, 6
- For children with DSWPD and psychiatric comorbidities, use 3 mg if <40 kg or 5 mg if >40 kg and administer at 18:00-19:00 for 4 weeks 6
Important Caveats
- Choose reputable formulations when possible for more reliable dosing 5
- The evidence for melatonin use in primary insomnia is considered low by some guidelines, and many studies on melatonin are of short duration, limiting conclusions about long-term safety 5
Melatonin Dosage and Administration
Adult Dosing Recommendations
- Prolonged-release melatonin at 2 mg has shown significant reduction in sleep latency specifically in elderly patients (65-80 years) 9
- The American Academy of Sleep Medicine suggests against using melatonin for primary insomnia in adults (weak recommendation) 10
Dosing Based on Clinical Condition
- For primary insomnia, 2 mg doses of melatonin showed minimal efficacy for sleep onset, maintenance, or quality, leading to a weak recommendation against its use by the American Academy of Sleep Medicine 10
Important Clinical Considerations
- Slow-release melatonin appears less effective than immediate-release formulations for sleep onset 9, 10
Safety Profile
- Caution is advised when prescribing melatonin to patients taking warfarin and to patients with epilepsy due to case reports of potential interactions 11
Quality Control Considerations
- United States Pharmacopeial Convention Verified formulations can be considered most reliable for melatonin 11
Melatonin Dosing and Administration Guidelines for Sleep Disorders
Adult and Pediatric Dosing Recommendations
- For elderly patients (>55 years), prolonged-release melatonin at 2 mg has shown some benefit, though the evidence is considered low quality, according to the American Academy of Sleep Medicine 12
- For children with DSWPD without comorbidities, a weight-based dose of 0.15 mg/kg taken 1.5-2.0 hours before habitual bedtime is recommended, as suggested by the American Academy of Sleep Medicine 13
- For children with DSWPD and psychiatric comorbidities (including autism spectrum disorders), fast-release melatonin at 3-5 mg is recommended, as stated by the American Academy of Pediatrics 14 and 15
Treatment Duration and Effectiveness
- For children without comorbidities, as little as 6 nights of treatment has demonstrated effectiveness, according to the American Academy of Sleep Medicine 13
- The American Academy of Sleep Medicine suggests against using melatonin for primary insomnia in adults (weak recommendation) due to limited evidence of efficacy 12
Melatonin Dosage and Administration
Adult Dosing
- The maximum recommended dose is typically 12-15 mg, with doses above 10 mg potentially causing receptor desensitization 16
- For REM sleep behavior disorder, doses range from 3-12 mg at bedtime 16
Safety Profile
- Common mild side effects include morning headache, morning sleepiness, and gastrointestinal upset 16
- Use caution in patients taking warfarin or those with epilepsy due to potential interactions 16